Eucope Visual

EUCOPE News- and Pressarchives

Brexit: Deal or no deal, the health of European patients must not suffer

Wednesday, September 19th, 2018 in Brexit, News, Press Releases

With the Brexit clock ticking, both sides are now preparing for a possible ’no deal’ Brexit, which could impact on patient and public health across the EU27. The European health community will express their concern that with time running out, no substantial progress has been made on those areas affecting ... read more...

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

Friday, June 22nd, 2018 in News, Press Releases

The pharmaceutical industry represented by AESGP. We believe that EU cooperation on joint clinical assessments and joint scientific consultations has the potential to contribute to expedite patients’ access to medicines in Europe. It is a unique opportunity for greater alignment on clinical evidence generation requirements, ensuring consistency, transparency and synergies in ... read more...

Better Regulation, SMEs and intellectual property: there is work to be done!

Friday, April 6th, 2018 in News, Press Releases

On 13 March 2018, EUCOPE co-organised with Comitology.eu a breakfast discussion on “Future proofing EU policies for SMEs –  a Case Study on Intellectual Property Rights”. Attended by over 30 commercial and institutional stakeholders as well as press and academia, the breakfast discussion touched upon the impact of SMEs on the ... read more...

Internship opportunity at EUCOPE

Friday, April 6th, 2018 in News, Newsletter

EUCOPE is seeking a new intern!   Starting date & period : as of 20 April 2018, for a period of 5-6 months. Place of internship: Brussels, Belgium Job Description The internship covers all kind of public affairs activities, from monitoring of health-related legislative developments, drafting reports and analyses to stakeholder meetings but also online communications, ... read more...

Associations representing the European and British life science industry respond to the European Council approving terms of the transition period agreed between the UK Government and EU.

Friday, March 23rd, 2018 in News, Press Releases

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today responded to the European Council approving terms of the transition period agreed between the UK Government and EU. Statement in response to the EU Council ... read more...